Keyphrases
Inflammatory Monocytes
100%
Pancreatic Cancer
100%
Patient Survival
100%
CCR2
100%
Chemokine (C-C motif) Ligand 2 (CCL2)
100%
Tumor
37%
Bone Marrow
37%
Monocytes
25%
Inflammatory Macrophages
25%
Tumor Resection
25%
Human Pancreatic Cancer
25%
Liver
12%
Cancer Tumor
12%
Tumor Growth
12%
Macrophages
12%
Metastasis
12%
Primary Tumor
12%
Normal Pancreas
12%
Survival Analysis
12%
CD8+ T Cells
12%
Peripheral Blood
12%
Tumor Immunity
12%
Improved Survival
12%
CCR2 Inhibitors
12%
Blood Monocytes
12%
Patient with Tumor
12%
Cancer Targeting
12%
Orthotopic Model
12%
T Cell Infiltration
12%
CD14+
12%
Monocyte Recruitment
12%
Pancreatic Cancer Progression
12%
Immunotherapeutic Strategy
12%
Novel Predictor
12%
Immunosuppressive Properties
12%
Immunotherapy Targets
12%
Pre-metastatic
12%
Immunology and Microbiology
CCR2
100%
CCL2
100%
Prevalence
57%
Macrophage
42%
Immunosuppressive Drug
28%
Cytotoxic T-Cell
14%
Pancreas
14%
CD14
14%
Medicine and Dentistry
Pancreas Cancer
100%
Neoplasm
45%
Prevalence
36%
Macrophage
27%
Cancer Surgery
18%
Immunosuppressive Drug
18%
Metastatic Carcinoma
9%
Primary Tumor
9%
Cellular Infiltration
9%
Cytotoxic T-Cell
9%
Tumor Progression
9%
Survival Analysis
9%
Diseases
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Neoplasm
63%
Prevalence
36%
Immunosuppressive Agent
18%
Tumor Growth
9%
Primary Tumor
9%
CD8 Antigen
9%
Diseases
9%